Noveris Health Sciences is trading at CA$1.12 (+7.21%) as the stock recovers from a period of high volatility and recent sharp swings.
- The gains follow a 10.7% drop on July 29, when speculative positions unwound amid a broader market shift toward risk-off sentiment.
- With no fresh company-specific announcements reported for July 30, the move likely reflects a technical bounce in the volatile small-cap name alongside firmer broader U.S. equities.